Hawthorne Effect Completes $20 Million Series A Round of Financing to Decentralize Clinical Trials

SAN FRANCISCO: SAN FRANCISCO, June 9, 2021 /PRNewswire/ -- Hawthorne Effectâ„¢, a solution for decentralizing clinical trials, today announced the successful closing of a $20 million Series A round of funding to alleviate key issues related to patient recruitment and retention via its tech-driven platform and expansive network of medical...

Click to view original post